Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
17
CMXHF Quote, Financials, Valuation and Earnings
Last price:
$113.75
Seasonality move
:
6.7%
Day range:
$118.55 - $126.11
52-week range:
$107.24 - $184.09
Dividend yield:
0%
P/E ratio:
19.27x
P/S ratio:
3.75x
P/B ratio:
4.29x
Volume:
180
Avg. volume:
1K
1-year change:
-30.71%
Market cap:
$57.7B
Revenue:
$15.4B
EPS (TTM):
$2.09
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CMXHF
CSL Ltd.
|
-- | -- | -- | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | $12.00 |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | $9.50 |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -- | -- | $19.01 |
|
PPCB
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CMXHF
CSL Ltd.
|
$118.99 | -- | $57.7B | 19.27x | $1.31 | 0% | 3.75x |
|
ATHE
Alterity Therapeutics Ltd.
|
$3.29 | $12.00 | $59.6M | -- | $0.00 | 0% | 3.58x |
|
IMMP
Immutep Ltd.
|
$2.58 | $9.50 | $375.5M | -- | $0.00 | 0% | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
$10.43 | $19.01 | $17.4M | -- | $0.00 | 0% | 471.27x |
|
PPCB
|
$11.98 | -- | $158.1K | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CMXHF
CSL Ltd.
|
39.2% | 0.317 | -- | 0.84x |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -1.575 | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | 0.640 | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-6.76% | 5.445 | 5.57% | 0.07x |
|
PPCB
|
-- | 4.794 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CMXHF
CSL Ltd.
|
$4.3B | $2B | 8.85% | 14.06% | 33.52% | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -784.09% | -1083.16% | -- | -- |
|
PPCB
|
-- | -$290.8K | -- | -- | -- | -$235.5K |
CSL Ltd. vs. Competitors
-
Which has Higher Returns CMXHF or ATHE?
Alterity Therapeutics Ltd. has a net margin of 24.44% compared to CSL Ltd.'s net margin of --. CSL Ltd.'s return on equity of 14.06% beat Alterity Therapeutics Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CMXHFCSL Ltd.52.1% $4.13 $32.5B ATHEAlterity Therapeutics Ltd.-- -- -- -
What do Analysts Say About CMXHF or ATHE?
CSL Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Alterity Therapeutics Ltd. has an analysts' consensus of $12.00 which suggests that it could grow by 264.74%. Given that Alterity Therapeutics Ltd. has higher upside potential than CSL Ltd., analysts believe Alterity Therapeutics Ltd. is more attractive than CSL Ltd..
Company Buy Ratings Hold Ratings Sell Ratings CMXHFCSL Ltd.0 0 0 ATHEAlterity Therapeutics Ltd.0 0 0 -
Is CMXHF or ATHE More Risky?
CSL Ltd. has a beta of 0.692, which suggesting that the stock is 30.848% less volatile than S&P 500. In comparison Alterity Therapeutics Ltd. has a beta of 0.023, suggesting its less volatile than the S&P 500 by 97.656%.
-
Which is a Better Dividend Stock CMXHF or ATHE?
CSL Ltd. has a quarterly dividend of $1.31 per share corresponding to a yield of 0%. Alterity Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CSL Ltd. pays 47.22% of its earnings as a dividend. Alterity Therapeutics Ltd. pays out -- of its earnings as a dividend. CSL Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CMXHF or ATHE?
CSL Ltd. quarterly revenues are $8.2B, which are larger than Alterity Therapeutics Ltd. quarterly revenues of --. CSL Ltd.'s net income of $2B is higher than Alterity Therapeutics Ltd.'s net income of --. Notably, CSL Ltd.'s price-to-earnings ratio is 19.27x while Alterity Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CSL Ltd. is 3.75x versus 3.58x for Alterity Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CMXHFCSL Ltd.3.75x 19.27x $8.2B $2B ATHEAlterity Therapeutics Ltd.3.58x -- -- --
-
Which has Higher Returns CMXHF or IMMP?
Immutep Ltd. has a net margin of 24.44% compared to CSL Ltd.'s net margin of --. CSL Ltd.'s return on equity of 14.06% beat Immutep Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CMXHFCSL Ltd.52.1% $4.13 $32.5B IMMPImmutep Ltd.-- -- -- -
What do Analysts Say About CMXHF or IMMP?
CSL Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Immutep Ltd. has an analysts' consensus of $9.50 which suggests that it could grow by 268.22%. Given that Immutep Ltd. has higher upside potential than CSL Ltd., analysts believe Immutep Ltd. is more attractive than CSL Ltd..
Company Buy Ratings Hold Ratings Sell Ratings CMXHFCSL Ltd.0 0 0 IMMPImmutep Ltd.1 0 0 -
Is CMXHF or IMMP More Risky?
CSL Ltd. has a beta of 0.692, which suggesting that the stock is 30.848% less volatile than S&P 500. In comparison Immutep Ltd. has a beta of 1.925, suggesting its more volatile than the S&P 500 by 92.469%.
-
Which is a Better Dividend Stock CMXHF or IMMP?
CSL Ltd. has a quarterly dividend of $1.31 per share corresponding to a yield of 0%. Immutep Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CSL Ltd. pays 47.22% of its earnings as a dividend. Immutep Ltd. pays out -- of its earnings as a dividend. CSL Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CMXHF or IMMP?
CSL Ltd. quarterly revenues are $8.2B, which are larger than Immutep Ltd. quarterly revenues of --. CSL Ltd.'s net income of $2B is higher than Immutep Ltd.'s net income of --. Notably, CSL Ltd.'s price-to-earnings ratio is 19.27x while Immutep Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CSL Ltd. is 3.75x versus -- for Immutep Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CMXHFCSL Ltd.3.75x 19.27x $8.2B $2B IMMPImmutep Ltd.-- -- -- --
-
Which has Higher Returns CMXHF or KZIA?
Kazia Therapeutics Ltd. has a net margin of 24.44% compared to CSL Ltd.'s net margin of --. CSL Ltd.'s return on equity of 14.06% beat Kazia Therapeutics Ltd.'s return on equity of -1083.16%.
Company Gross Margin Earnings Per Share Invested Capital CMXHFCSL Ltd.52.1% $4.13 $32.5B KZIAKazia Therapeutics Ltd.-- -- -$6.3M -
What do Analysts Say About CMXHF or KZIA?
CSL Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kazia Therapeutics Ltd. has an analysts' consensus of $19.01 which suggests that it could grow by 82.25%. Given that Kazia Therapeutics Ltd. has higher upside potential than CSL Ltd., analysts believe Kazia Therapeutics Ltd. is more attractive than CSL Ltd..
Company Buy Ratings Hold Ratings Sell Ratings CMXHFCSL Ltd.0 0 0 KZIAKazia Therapeutics Ltd.1 0 0 -
Is CMXHF or KZIA More Risky?
CSL Ltd. has a beta of 0.692, which suggesting that the stock is 30.848% less volatile than S&P 500. In comparison Kazia Therapeutics Ltd. has a beta of 1.672, suggesting its more volatile than the S&P 500 by 67.185%.
-
Which is a Better Dividend Stock CMXHF or KZIA?
CSL Ltd. has a quarterly dividend of $1.31 per share corresponding to a yield of 0%. Kazia Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CSL Ltd. pays 47.22% of its earnings as a dividend. Kazia Therapeutics Ltd. pays out -- of its earnings as a dividend. CSL Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CMXHF or KZIA?
CSL Ltd. quarterly revenues are $8.2B, which are larger than Kazia Therapeutics Ltd. quarterly revenues of --. CSL Ltd.'s net income of $2B is higher than Kazia Therapeutics Ltd.'s net income of --. Notably, CSL Ltd.'s price-to-earnings ratio is 19.27x while Kazia Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CSL Ltd. is 3.75x versus 471.27x for Kazia Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CMXHFCSL Ltd.3.75x 19.27x $8.2B $2B KZIAKazia Therapeutics Ltd.471.27x -- -- --
-
Which has Higher Returns CMXHF or PPCB?
has a net margin of 24.44% compared to CSL Ltd.'s net margin of --. CSL Ltd.'s return on equity of 14.06% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CMXHFCSL Ltd.52.1% $4.13 $32.5B PPCB-- -$0.00 -- -
What do Analysts Say About CMXHF or PPCB?
CSL Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that CSL Ltd. has higher upside potential than , analysts believe CSL Ltd. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings CMXHFCSL Ltd.0 0 0 PPCB0 0 0 -
Is CMXHF or PPCB More Risky?
CSL Ltd. has a beta of 0.692, which suggesting that the stock is 30.848% less volatile than S&P 500. In comparison has a beta of 1.881, suggesting its more volatile than the S&P 500 by 88.104%.
-
Which is a Better Dividend Stock CMXHF or PPCB?
CSL Ltd. has a quarterly dividend of $1.31 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CSL Ltd. pays 47.22% of its earnings as a dividend. pays out -- of its earnings as a dividend. CSL Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CMXHF or PPCB?
CSL Ltd. quarterly revenues are $8.2B, which are larger than quarterly revenues of --. CSL Ltd.'s net income of $2B is higher than 's net income of -$354.3K. Notably, CSL Ltd.'s price-to-earnings ratio is 19.27x while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CSL Ltd. is 3.75x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CMXHFCSL Ltd.3.75x 19.27x $8.2B $2B PPCB-- -- -- -$354.3K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
73
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 39x
Alerts
Buy
80
FEIM alert for Dec 15
Frequency Electronics, Inc. [FEIM] is down 3.51% over the past day.
Buy
57
MOD alert for Dec 15
Modine Manufacturing Co. [MOD] is up 1.79% over the past day.
Sell
42
OKLO alert for Dec 15
Oklo, Inc. [OKLO] is down 5.81% over the past day.
